{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:20:44Z","timestamp":1764919244597,"version":"3.46.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01556-8","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:42:50Z","timestamp":1747755770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation a novel kinase-related gene signature for predicting prognosis and responsiveness to immunotherapy in hepatocellular carcinoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Yaju","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianqiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA: A Cancer J Clin"},{"key":"1556_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1556_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1556_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ (Clinical research ed). 2020;371: m3544. https:\/\/doi.org\/10.1136\/bmj.m3544.","journal-title":"BMJ (Clinical research ed)"},{"key":"1556_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/s0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet (London, England). 2022;400:1345\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(22)01200-4.","journal-title":"Lancet (London, England)"},{"key":"1556_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"1556_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jhep.2018.10.009","volume":"70","author":"XY Zhang","year":"2019","unstructured":"Zhang XY, Ou J, Chen JY, Li WW. Predicting early hepatocellular carcinoma recurrence after resection: a comment for moving forward. J Hepatol. 2019;70:567\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.009.","journal-title":"J Hepatol"},{"key":"1556_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med. 2017;40:271\u201380. https:\/\/doi.org\/10.3892\/ijmm.2017.3036.","journal-title":"Int J Mol Med"},{"key":"1556_CR9","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912\u201334. https:\/\/doi.org\/10.1126\/science.1075762.","journal-title":"Science"},{"key":"1556_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0014-5793(03)00487-3","volume":"546","author":"A Rykx","year":"2003","unstructured":"Rykx A, De Kimpe L, Mikhalap S, Vantus T, Seufferlein T, Vandenheede JR, Van Lint J. Protein kinase D: a family affair. FEBS Lett. 2003;546:81\u20136. https:\/\/doi.org\/10.1016\/s0014-5793(03)00487-3.","journal-title":"FEBS Lett"},{"key":"1556_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1042\/bcj20230352","volume":"481","author":"KJ Rosenthal","year":"2024","unstructured":"Rosenthal KJ, Gordan JD, Scott JD. Protein kinase A and local signaling in cancer. Biochem J. 2024;481:1659\u201377. https:\/\/doi.org\/10.1042\/bcj20230352.","journal-title":"Biochem J"},{"key":"1556_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/14737140.2018.1527688","volume":"18","author":"R Kannaiyan","year":"2018","unstructured":"Kannaiyan R, Mahadevan D. A comprehensive review of protein kinase inhibitors for cancer therapy. Expert Rev Anticancer Ther. 2018;18:1249\u201370. https:\/\/doi.org\/10.1080\/14737140.2018.1527688.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1556_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature03160","volume":"432","author":"M Bettencourt-Dias","year":"2004","unstructured":"Bettencourt-Dias M, Giet R, Sinka R, Mazumdar A, Lock WG, Balloux F, Zafiropoulos PJ, Yamaguchi S, Winter S, Carthew RW, et al. Genome-wide survey of protein kinases required for cell cycle progression. Nature. 2004;432:980\u20137. https:\/\/doi.org\/10.1038\/nature03160.","journal-title":"Nature"},{"key":"1556_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2017.04.012","volume":"48","author":"N Isakov","year":"2018","unstructured":"Isakov N. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol. 2018;48:36\u201352. https:\/\/doi.org\/10.1016\/j.semcancer.2017.04.012.","journal-title":"Semin Cancer Biol"},{"key":"1556_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molbiopara.2017.01.008","volume":"215","author":"S Bennuru","year":"2017","unstructured":"Bennuru S, Lustigman S, Abraham D, Nutman TB. Metabolite profiling of infection-associated metabolic markers of onchocerciasis. Mol Biochem Parasitol. 2017;215:58\u201369. https:\/\/doi.org\/10.1016\/j.molbiopara.2017.01.008.","journal-title":"Mol Biochem Parasitol"},{"key":"1556_CR16","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/329098","volume":"2011","author":"A Bononi","year":"2011","unstructured":"Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, Giorgi C, Missiroli S, Poletti F, Rimessi A, et al. Protein kinases and phosphatases in the control of cell fate. Enzyme Res. 2011;2011: 329098. https:\/\/doi.org\/10.4061\/2011\/329098.","journal-title":"Enzyme Res"},{"key":"1556_CR17","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1172\/JCI76094","volume":"125","author":"S Gross","year":"2015","unstructured":"Gross S, Rahal R, Stransky N, Lengauer C, Hoeflich KP. Targeting cancer with kinase inhibitors. J Clin Invest. 2015;125:1780\u20139. https:\/\/doi.org\/10.1172\/JCI76094.","journal-title":"J Clin Invest"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc.2015.18","volume":"16","author":"ED Fleuren","year":"2016","unstructured":"Fleuren ED, Zhang L, Wu J, Daly RJ. The kinome \u201cat large\u201d in cancer. Nat Rev Cancer. 2016;16:83\u201398. https:\/\/doi.org\/10.1038\/nrc.2015.18.","journal-title":"Nat Rev Cancer"},{"key":"1556_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrclinonc.2017.127","volume":"14","author":"AM Schram","year":"2017","unstructured":"Schram AM, Chang MT, Jonsson P, Drilon A. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance. Nat Rev Clin Oncol. 2017;14:735\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2017.127.","journal-title":"Nat Rev Clin Oncol"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17:58. https:\/\/doi.org\/10.1186\/s12943-018-0782-4.","journal-title":"Mol Cancer"},{"key":"1556_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101128","volume":"297","author":"AE Yesilkanal","year":"2021","unstructured":"Yesilkanal AE, Johnson GL, Ramos AF, Rosner MR. New strategies for targeting kinase networks in cancer. J Biol Chem. 2021;297: 101128. https:\/\/doi.org\/10.1016\/j.jbc.2021.101128.","journal-title":"J Biol Chem"},{"key":"1556_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107059","volume":"200","author":"R Roskoski Jr","year":"2024","unstructured":"Roskoski R Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update. Pharmacol Res. 2024;200: 107059. https:\/\/doi.org\/10.1016\/j.phrs.2024.107059.","journal-title":"Pharmacol Res"},{"key":"1556_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-019-1607-3","volume":"574","author":"C Wang","year":"2019","unstructured":"Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;574:268\u201372. https:\/\/doi.org\/10.1038\/s41586-019-1607-3.","journal-title":"Nature"},{"key":"1556_CR24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(18)30207-1.","journal-title":"Lancet"},{"key":"1556_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.944000","volume":"12","author":"S Wei","year":"2022","unstructured":"Wei S, Zhang J, Shi R, Yu Z, Chen X, Wang H. Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. Front Oncol. 2022;12: 944000. https:\/\/doi.org\/10.3389\/fonc.2022.944000.","journal-title":"Front Oncol"},{"key":"1556_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"1556_CR27","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"1556_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","journal-title":"Bioinformatics"},{"key":"1556_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101419","volume":"20","author":"SY Lu","year":"2022","unstructured":"Lu SY, Hua J, Liu J, Wei MY, Liang C, Meng QC, Zhang B, Yu XJ, Wang W, Xu J. Construction of a paclitaxel-related competitive endogenous RNA network and identification of a potential regulatory axis in pancreatic cancer. Transl Oncol. 2022;20: 101419. https:\/\/doi.org\/10.1016\/j.tranon.2022.101419.","journal-title":"Transl Oncol"},{"key":"1556_CR30","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"1556_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12920-022-01413-7","volume":"15","author":"H Wang","year":"2022","unstructured":"Wang H, Lu X, Chen J. Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma. BMC Med Genomics. 2022;15:254. https:\/\/doi.org\/10.1186\/s12920-022-01413-7.","journal-title":"BMC Med Genomics"},{"key":"1556_CR32","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, Qian X, Wang M, He X, Wang T, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1:e36. https:\/\/doi.org\/10.1002\/imt2.36.","journal-title":"iMeta"},{"key":"1556_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"1556_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9: e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468.","journal-title":"PLoS ONE"},{"key":"1556_CR35","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:D955\u201361. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucleic Acids Res"},{"key":"1556_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102001","volume":"46","author":"Z Gui","year":"2024","unstructured":"Gui Z, Ye Y, Li Y, Ren Z, Wei N, Liu L, Wang H, Zhang M. Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer. Transl Oncol. 2024;46: 102001. https:\/\/doi.org\/10.1016\/j.tranon.2024.102001.","journal-title":"Transl Oncol"},{"key":"1556_CR37","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1038\/s41598-023-48653-w","volume":"13","author":"Y Ye","year":"2023","unstructured":"Ye Y, Zhang S, Jiang Y, Huang Y, Wang G, Zhang M, Gui Z, Wu Y, Bian G, Li P, et al. Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer. Sci Rep. 2023;13:21565. https:\/\/doi.org\/10.1038\/s41598-023-48653-w.","journal-title":"Sci Rep"},{"key":"1556_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107238","volume":"90","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zi Q, Xu K, Wang C, Chi Q. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Int Immunopharmacol. 2021;90: 107238. https:\/\/doi.org\/10.1016\/j.intimp.2020.107238.","journal-title":"Int Immunopharmacol"},{"key":"1556_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12935-019-0817-y","volume":"19","author":"J Long","year":"2019","unstructured":"Long J, Bai Y, Yang X, Lin J, Yang X, Wang D, He L, Zheng Y, Zhao H. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma. Cancer Cell Int. 2019;19:90. https:\/\/doi.org\/10.1186\/s12935-019-0817-y.","journal-title":"Cancer Cell Int"},{"key":"1556_CR40","doi-asserted-by":"publisher","first-page":"15990","DOI":"10.18632\/aging.203056","volume":"13","author":"L Zhang","year":"2021","unstructured":"Zhang L, Tao H, Li J, Zhang E, Liang H, Zhang B. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma. Aging (Albany NY). 2021;13:15990\u20136008. https:\/\/doi.org\/10.18632\/aging.203056.","journal-title":"Aging (Albany NY)"},{"key":"1556_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/21655979.2020.1787764","volume":"11","author":"J Liu","year":"2020","unstructured":"Liu J, Sun G, Pan S, Qin M, Ouyang R, Li Z, Huang J. The Cancer Genome Atlas (TCGA) based m(6)A methylation-related genes predict prognosis in hepatocellular carcinoma. Bioengineered. 2020;11:759\u201368. https:\/\/doi.org\/10.1080\/21655979.2020.1787764.","journal-title":"Bioengineered"},{"key":"1556_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12967-020-02492-9","volume":"18","author":"B Zhang","year":"2020","unstructured":"Zhang B, Tang B, Gao J, Li J, Kong L, Qin L. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. J Transl Med. 2020;18:342. https:\/\/doi.org\/10.1186\/s12967-020-02492-9.","journal-title":"J Transl Med"},{"key":"1556_CR43","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1158\/0008-5472.CAN-10-4026","volume":"71","author":"VK Hill","year":"2011","unstructured":"Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C, Maher ER, Latif F. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res. 2011;71:2988\u201399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4026.","journal-title":"Cancer Res"},{"key":"1556_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41388-018-0442-6","volume":"38","author":"CY Lai","year":"2019","unstructured":"Lai CY, Liu H, Tin KX, Huang Y, Yeh KH, Peng HW, Chen HD, He JY, Chiang YJ, Liu CS, et al. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells. Oncogene. 2019;38:317\u201331. https:\/\/doi.org\/10.1038\/s41388-018-0442-6.","journal-title":"Oncogene"},{"key":"1556_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1756-8935-8-2","volume":"8","author":"RK Athwal","year":"2015","unstructured":"Athwal RK, Walkiewicz MP, Baek S, Fu S, Bui M, Camps J, Ried T, Sung MH, Dalal Y. CENP-A nucleosomes localize to transcription factor hotspots and subtelomeric sites in human cancer cells. Epigen Chromatin. 2015;8:2. https:\/\/doi.org\/10.1186\/1756-8935-8-2.","journal-title":"Epigen Chromatin"},{"key":"1556_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.907120","volume":"10","author":"C Renaud-Pageot","year":"2022","unstructured":"Renaud-Pageot C, Quivy JP, Lochhead M, Almouzni G. CENP-a regulation and cancer. Front Cell Dev Biol. 2022;10: 907120. https:\/\/doi.org\/10.3389\/fcell.2022.907120.","journal-title":"Front Cell Dev Biol"},{"key":"1556_CR47","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/0008-5472.CAN-18-3987","volume":"80","author":"Y Wang","year":"2020","unstructured":"Wang Y, Huang J, Li B, Xue H, Tricot G, Hu L, Xu Z, Sun X, Chang S, Gao L, et al. A small-molecule inhibitor targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2020;80:536\u201348. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3987.","journal-title":"Cancer Res"},{"key":"1556_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13046-019-1401-y","volume":"38","author":"MX Zhu","year":"2019","unstructured":"Zhu MX, Wei CY, Zhang PF, Gao DM, Chen J, Zhao Y, Dong SS, Liu BB. Elevated TRIP13 drives the AKT\/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4. J Exp Clin Cancer Res. 2019;38:409. https:\/\/doi.org\/10.1186\/s13046-019-1401-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"1556_CR49","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.dld.2021.10.003","volume":"54","author":"L Bao","year":"2022","unstructured":"Bao L, Li P, Zhao H, Chen L, Wang Y, Liang S, Liu J. Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324-3p\/GLYATL1 axis. Dig Liver Dis. 2022;54:918\u201326. https:\/\/doi.org\/10.1016\/j.dld.2021.10.003.","journal-title":"Dig Liver Dis"},{"key":"1556_CR50","doi-asserted-by":"publisher","first-page":"11097","DOI":"10.1111\/jcmm.17032","volume":"25","author":"XH Cui","year":"2021","unstructured":"Cui XH, Peng QJ, Li RZ, Lyu XJ, Zhu CF, Qin XH. Cell division cycle associated 8: a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. J Cell Mol Med. 2021;25:11097\u2013112. https:\/\/doi.org\/10.1111\/jcmm.17032.","journal-title":"J Cell Mol Med"},{"key":"1556_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12935-021-01850-x","volume":"21","author":"Y Shuai","year":"2021","unstructured":"Shuai Y, Fan E, Zhong Q, Chen Q, Feng G, Gou X, Zhang G. CDCA8 as an independent predictor for a poor prognosis in liver cancer. Cancer Cell Int. 2021;21:159. https:\/\/doi.org\/10.1186\/s12935-021-01850-x.","journal-title":"Cancer Cell Int"},{"key":"1556_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12032-014-0248-5","volume":"31","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhao Z, Bao X, Fang Y, Ni P, Chen Q, Zhang W, Deng A. Borealin\/Dasra B is overexpressed in colorectal cancers and contributes to proliferation of cancer cells. Med Oncol. 2014;31:248. https:\/\/doi.org\/10.1007\/s12032-014-0248-5.","journal-title":"Med Oncol"},{"key":"1556_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4048\/jbc.2019.22.e29","volume":"22","author":"D Yu","year":"2019","unstructured":"Yu D, Shi L, Bu Y, Li W. Cell division cycle associated 8 is a key regulator of tamoxifen resistance in breast cancer. J Breast Cancer. 2019;22:237\u201347. https:\/\/doi.org\/10.4048\/jbc.2019.22.e29.","journal-title":"J Breast Cancer"},{"key":"1556_CR54","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1177\/1535370216655908","volume":"241","author":"P Dou","year":"2016","unstructured":"Dou P, Zhang D, Cheng Z, Zhou G, Zhang L. PKIB promotes cell proliferation and the invasion-metastasis cascade through the PI3K\/Akt pathway in NSCLC cells. Exp Biol Med (Maywood). 2016;241:1911\u20138. https:\/\/doi.org\/10.1177\/1535370216655908.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1556_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.965838","volume":"12","author":"R Wan","year":"2022","unstructured":"Wan R, Yang G, Liu Q, Fu X, Liu Z, Miao H, Liu H, Huang W. PKIB involved in the metastasis and survival of osteosarcoma. Front Oncol. 2022;12: 965838. https:\/\/doi.org\/10.3389\/fonc.2022.965838.","journal-title":"Front Oncol"},{"key":"1556_CR56","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3969\/j.issn.1673-4254.2017.06.05","volume":"37","author":"HW Wang","year":"2017","unstructured":"Wang HW, Duan ZJ, Hu SS, Wang S. Expression of cAMP-dependent protein kinase inhibitor beta in colorectal carcinoma and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:744\u20139. https:\/\/doi.org\/10.3969\/j.issn.1673-4254.2017.06.05.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1556_CR57","first-page":"1264","volume":"21","author":"JB Zhang","year":"2017","unstructured":"Zhang JB, Song W, Wang YY, Liu MG, Sun MM, Liu H. Study on correlation between PKIB and pAkt expression in breast cancer tissues. Eur Rev Med Pharmacol Sci. 2017;21:1264\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1556_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13195","volume":"9","author":"Z Jin","year":"2023","unstructured":"Jin Z, Peng F, Zhang C, Tao S, Xu D, Zhu Z. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon. 2023;9: e13195. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13195.","journal-title":"Heliyon"},{"key":"1556_CR59","doi-asserted-by":"publisher","first-page":"26206","DOI":"10.18632\/oncotarget.8441","volume":"7","author":"C Shi","year":"2016","unstructured":"Shi C, Huang D, Lu N, Chen D, Zhang M, Yan Y, Deng L, Lu Q, Lu H, Luo S. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis. Oncotarget. 2016;7:26206\u201319. https:\/\/doi.org\/10.18632\/oncotarget.8441.","journal-title":"Oncotarget"},{"key":"1556_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228470","author":"KM Pflug","year":"2020","unstructured":"Pflug KM, Sitcheran R. Targeting NF-kappaB-Inducing Kinase (NIK) in immunity, inflammation, and cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21228470.","journal-title":"Int J Mol Sci"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01556-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:50:40Z","timestamp":1764917440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01556-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The work has not been published previously, and it is not under consideration for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research protocol was approved by the by the Ethics Committee of the Zhejiang Cancer Hospital (Ethical Approval Number: IRB-2021-234). All procedures were performed strictly in compliance with the Declaration of Helsinki 1964 or equivalent ethical principles. All patients involved in this study had given their\u00a0informed consent\u00a0before study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"170"}}